Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
about
Role of Akt signaling in resistance to DNA-targeted therapyChemoresistance and targeted therapies in ovarian and endometrial cancersTWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells.
P2860
Downregulation of AKT reverses platinum resistance of human ovarian cancers in vitro.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Downregulation of AKT reverses ...... cancers in vitro.
@en
Downregulation of AKT reverses ...... cancers in vitro.
@nl
type
label
Downregulation of AKT reverses ...... cancers in vitro.
@en
Downregulation of AKT reverses ...... cancers in vitro.
@nl
prefLabel
Downregulation of AKT reverses ...... cancers in vitro.
@en
Downregulation of AKT reverses ...... cancers in vitro.
@nl
P2093
P356
P1433
P1476
Downregulation of AKT reverses ...... n cancers in vitro
@en
P2093
J Wischhusen
S E Segerer
S F M Häussler
P304
P356
10.3892/OR.2012.2041
P577
2012-09-18T00:00:00Z